Treata is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Treata acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products directly in Canada and indirectly through partners in the U.S., and South America.